Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Abiraterone Acetate MeSH Descriptor Data 2025


MeSH Heading
Abiraterone Acetate
Tree Number(s)
D04.210.500.054.079.065
Unique ID
D000069501
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069501
Scope Note
An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.
Entry Term(s)
17-(3-pyridyl)-5,16-androstadien-3beta-acetate
CB 7630
CB-7630
CB7630
Zytiga
Pharm Action
Antineoplastic Agents
Steroid Synthesis Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Registry Numbers
EM5OCB9YJ6
154229-18-2
0
Related Numbers
154229-18-2
Public MeSH Note
2016; ABIRATERONE ACETATE was indexed under ANDROSTENES 1994-2015
History Note
2016 (1994)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2016/05/27
Abiraterone Acetate Preferred
17-(3-pyridyl)-5,16-androstadien-3beta-acetate Narrower
CB 7630 Narrower
Zytiga Narrower
page delivered in 0.144s